These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 15117981)
1. First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. Brandes AA; Basso U; Reni M; Vastola F; Tosoni A; Cavallo G; Scopece L; Ferreri AJ; Panucci MG; Monfardini S; Ermani M; J Clin Oncol; 2004 May; 22(9):1598-604. PubMed ID: 15117981 [TBL] [Abstract][Full Text] [Related]
2. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079 [TBL] [Abstract][Full Text] [Related]
3. Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO). Brandes AA; Tosoni A; Cavallo G; Bertorelle R; Gioia V; Franceschi E; Biscuola M; Blatt V; Crinò L; Ermani M; Br J Cancer; 2006 Nov; 95(9):1155-60. PubMed ID: 17024124 [TBL] [Abstract][Full Text] [Related]
4. Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients. Wang Y; Kong X; Guo Y; Wang R; Ma W Medicine (Baltimore); 2017 Mar; 96(10):e6261. PubMed ID: 28272232 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. Herrlinger U; Rieger J; Koch D; Loeser S; Blaschke B; Kortmann RD; Steinbach JP; Hundsberger T; Wick W; Meyermann R; Tan TC; Sommer C; Bamberg M; Reifenberger G; Weller M J Clin Oncol; 2006 Sep; 24(27):4412-7. PubMed ID: 16983109 [TBL] [Abstract][Full Text] [Related]
6. Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Brandes AA; Tosoni A; Franceschi E; Blatt V; Santoro A; Faedi M; Amistà P; Gardiman M; Labianca R; Bianchini C; Ermani M; Reni M Cancer Chemother Pharmacol; 2009 Sep; 64(4):769-75. PubMed ID: 19169684 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. Groves MD; Puduvalli VK; Hess KR; Jaeckle KA; Peterson P; Yung WK; Levin VA J Clin Oncol; 2002 Mar; 20(5):1383-8. PubMed ID: 11870183 [TBL] [Abstract][Full Text] [Related]
8. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. Silvani A; Eoli M; Salmaggi A; Lamperti E; Maccagnano E; Broggi G; Boiardi A J Neurooncol; 2004 Jan; 66(1-2):203-8. PubMed ID: 15015788 [TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. Jaeckle KA; Hess KR; Yung WK; Greenberg H; Fine H; Schiff D; Pollack IF; Kuhn J; Fink K; Mehta M; Cloughesy T; Nicholas MK; Chang S; Prados M; J Clin Oncol; 2003 Jun; 21(12):2305-11. PubMed ID: 12805331 [TBL] [Abstract][Full Text] [Related]
12. Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. Groves MD; Puduvalli VK; Gilbert MR; Levin VA; Conrad CA; Liu VH; Hunter K; Meyers C; Hess KR; Alfred Yung WK Br J Cancer; 2009 Aug; 101(4):615-20. PubMed ID: 19672263 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide. Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172 [TBL] [Abstract][Full Text] [Related]
14. A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma. Sepúlveda JM; Belda-Iniesta C; Gil-Gil M; Pérez-Segura P; Berrocal A; Reynés G; Gallego O; Capellades J; Ordoñez JM; La Orden B; Balañá C Clin Transl Oncol; 2015 Sep; 17(9):743-50. PubMed ID: 26033428 [TBL] [Abstract][Full Text] [Related]
15. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma. Huang J; Chaudhary R; Cohen AL; Fink K; Goldlust S; Boockvar J; Chinnaiyan P; Wan L; Marcus S; Campian JL J Neurooncol; 2019 May; 142(3):537-544. PubMed ID: 30771200 [TBL] [Abstract][Full Text] [Related]
16. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Brada M; Hoang-Xuan K; Rampling R; Dietrich PY; Dirix LY; Macdonald D; Heimans JJ; Zonnenberg BA; Bravo-Marques JM; Henriksson R; Stupp R; Yue N; Bruner J; Dugan M; Rao S; Zaknoen S Ann Oncol; 2001 Feb; 12(2):259-66. PubMed ID: 11300335 [TBL] [Abstract][Full Text] [Related]
17. Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. Scoccianti S; Detti B; Sardaro A; Iannalfi A; Meattini I; Leonulli BG; Borghesi S; Martinelli F; Bordi L; Ammannati F; Biti G Anticancer Drugs; 2008 Jul; 19(6):613-20. PubMed ID: 18525321 [TBL] [Abstract][Full Text] [Related]
18. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach. Perry JR; Rizek P; Cashman R; Morrison M; Morrison T Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530 [TBL] [Abstract][Full Text] [Related]
19. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. Groves MD; Puduvalli VK; Chang SM; Conrad CA; Gilbert MR; Tremont-Lukats IW; Liu TJ; Peterson P; Schiff D; Cloughesy TF; Wen PY; Greenberg H; Abrey LE; DeAngelis LM; Hess KR; Lamborn KR; Prados MD; Yung WK J Neurooncol; 2007 Feb; 81(3):271-7. PubMed ID: 17031561 [TBL] [Abstract][Full Text] [Related]